Vasoactive intestinal peptide (VIP, aviptadil) studies: 420 papers with results
Page 8 of 9
- Substance P-, somatostatin-, vasoactive intestinal peptide- and cholecystokinin-like levels in the spinal cord of polyarthritic rats.
Chery-Croze S · Brain research · 1985
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Effects of Ninjin-to on levels of brain-gut peptides (motilin, vasoactive intestinal peptide, gastrin, and somatostatin) in human plasma.
Naito T · Biological & pharmaceutical bulletin · 2001
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Distribution of vasoactive intestinal peptide- and peptide histidine isoleucine amide-like immunoreactive neurons and fibers in the thoracic spinal cord of the rat.
Sasek CA · Brain research · 1991
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Arginine vasopressin and vasoactive intestinal polypeptide fibers make appositions with gonadotropin-releasing hormone and estrogen receptor cells in the diurnal rodent Arvicanthis niloticus.
Mahoney MM · Brain research · 2005
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Substance P and vasoactive intestinal peptide in serotonin-induced nasal secretions in normal subjects.
Tønnesen P · Allergy · 1987
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Lack of circadian patterns in vasoactive intestinal polypeptide release and variability in vasopressin release in vole suprachiasmatic nuclei in vitro.
Gerkema MP · Neuroscience letters · 1999
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Straight leg raising test and lumbar cerebrospinal fluid levels of vasoactive intestinal polypeptide and somatostatin in patients with low back pain.
Grönblad M · Spine · 1994
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects.
Cugini P · Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 1992
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H · The Journal of pharmacy and pharmacology · 2002
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Vasoactive intestinal polypeptide levels and distribution in the penis of old rats.
Amenta F · Journal of neural transmission · 1987
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Vasoactive intestinal peptide inhibition of stimulated gastric secretion. I. Inhibition of meat-stimulated gastric secretion.
Ebeid AM · American journal of surgery · 1980
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Glucagon, secretin and vasoactive intestinal polypeptide immunoreactivities in rat gut after jejuno-ileal bypass and resection.
Murphy RF · Digestion · 1985
Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result
- Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study.
Dinsmore WW · BJU international · 1999
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 18 results
- A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction.
Sandhu D · International journal of impotence research · 1999
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 13 results
- PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.
Thakur ML · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2004
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 9 results
- Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile.
Yadav M · Journal of immunology (Baltimore, Md. : 1950) · 2008
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 8 results
- Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice.
Bangale Y · Peptides · 2002
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 8 results
- In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.
Reubi JC · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 1995
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 7 results
- Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H · The Journal of pharmacology and experimental therapeutics · 2002
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 7 results
- Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
Yukawa T · International journal of molecular medicine · 2007
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 6 results
- Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate.
Shah PJ · Current medical research and opinion · 2007
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 6 results
- Differential effect of arachidonic acid on the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelium during sexual maturation.
Carmena MJ · Peptides · 1992
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 6 results
- Lack of effect of vasoactive intestinal peptide antagonists on blood flow in the rat thyroid.
Michalkiewicz M · Peptides · 1991
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 6 results
- An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
Gozes I · The Journal of pharmacology and experimental therapeutics · 1991
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.
Lara-Marquez M · Journal of immunology (Baltimore, Md. : 1950) · 2001
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine.
Banks MR · British journal of pharmacology · 2005
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.
Igarashi H · The Journal of pharmacology and experimental therapeutics · 2002
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation.
Zhang K · Regulatory peptides · 2007
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
Robichon A · Endocrinology · 1987
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Structure-activity studies on the vasoactive intestinal peptide pharmacophore. 1. Analogs of tyrosine.
Bolin DR · International journal of peptide and protein research · 1995
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 5 results
- Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons.
Aton SJ · Nature neuroscience · 2005
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC · Cancer research · 2000
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
Reubi JC · Cancer research · 1996
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Administration of antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine attenuates ether-induced prolactin secretion in rats.
Kaji H · Neuroendocrinology · 1985
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin.
Wilkins BW · Journal of applied physiology (Bethesda, Md. : 1985) · 2005
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
Rekasi Z · Proceedings of the National Academy of Sciences of the United States of America · 2000
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force.
Hinkle RT · Journal of applied physiology (Bethesda, Md. : 1985) · 2005
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- The biological relevance of HPLC-purified vasoactive intestinal polypeptide monoiodinated at tyrosine 10 or tyrosine 22.
Marie JC · Regulatory peptides · 1985
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of schistosome-infected mice.
Metwali A · Journal of immunology (Baltimore, Md. : 1950) · 1996
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS.
Gross PC · Journal of pharmaceutical and biomedical analysis · 2014
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Comparison of cyclic and linear analogs of vasoactive intestinal peptide.
Bolin DR · Drug design and discovery · 1996
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Colonic mucosal vasoactive intestinal peptide receptors in malformations of the enteric nervous system are reduced compared with morphologically normal innervated colon.
Schmittenbecher PP · Pediatric surgery international · 2002
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Effect of immunisation against vasoactive intestinal polypeptide on gastric corpus tone and motility in the ferret.
Grundy D · Gut · 1992
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Suppression of 125I-vasoactive intestinal polypeptide binding sites in arteries of the hamster seminal vesicle following castration.
Barroso CP · The Histochemical journal · 1999
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results
- Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice.
Brown TM · Journal of neurophysiology · 2007
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results
- Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans.
Bennett LA · The Journal of physiology · 2003
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results
- Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide inhibit feeding in the chick brain by different mechanisms.
Tachibana T · Neuroscience letters · 2003
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results
- Measurement of vasoactive intestinal peptide using a competitive fluorescent microsphere immunoassay or ELISA in human blood samples.
Song EY · Journal of immunological methods · 2005
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results
- Tumor-promoting phorbol esters interfere with the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelial cells.
Escudero F · Biochemical and biophysical research communications · 1987
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results
- Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M · Endocrinology · 1987
Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results